News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
202,966 Results
Type
Article (8465)
Company Profile (51)
Press Release (194450)
Section
Business (54538)
Career Advice (131)
Deals (6525)
Drug Delivery (11)
Drug Development (38201)
Employer Resources (23)
FDA (6550)
Job Trends (4393)
News (104515)
Policy (8092)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
Academia (997)
Accelerated approval (1)
Adcomms (8)
Allergies (36)
Alliances (13147)
ALS (38)
Alzheimer's disease (593)
Antibody-drug conjugate (ADC) (36)
Approvals (6590)
Artificial intelligence (64)
Autoimmune disease (7)
Automation (4)
Bankruptcy (30)
Best Places to Work (4086)
BIOSECURE Act (3)
Biosimilars (19)
Biotechnology (43)
Bladder cancer (35)
Brain cancer (10)
Breast cancer (145)
Cancer (978)
Cardiovascular disease (64)
Career advice (113)
Career pathing (2)
CAR-T (54)
Cell therapy (162)
Cervical cancer (9)
Clinical research (32662)
Collaboration (256)
Compensation (71)
Complete response letters (4)
COVID-19 (688)
CRISPR (13)
C-suite (82)
Cystic fibrosis (44)
Data (1132)
Denatured (8)
Depression (37)
Diabetes (89)
Diagnostics (1778)
Digital health (5)
Diversity (3)
Diversity, equity & inclusion (8)
Drug discovery (34)
Drug pricing (10)
Drug shortages (2)
Duchenne muscular dystrophy (45)
Earnings (16915)
Editorial (5)
Employer branding (1)
Employer resources (21)
Events (35210)
Executive appointments (284)
FDA (7068)
Featured Employer (7)
Frontotemporal dementia (4)
Funding (241)
Gene editing (29)
Generative AI (2)
Gene therapy (88)
GLP-1 (139)
Government (1395)
Guidances (13)
Healthcare (6775)
Huntington's disease (8)
IgA nephropathy (9)
Immunology and inflammation (33)
Indications (12)
Infectious disease (711)
Inflammatory bowel disease (58)
Inflation Reduction Act (6)
Influenza (13)
Intellectual property (20)
Interviews (14)
IPO (3155)
IRA (8)
Job creations (516)
Job search strategy (109)
Kidney cancer (8)
Labor market (4)
Layoffs (79)
Leadership (2)
Legal (978)
Liver cancer (28)
Lung cancer (144)
Lymphoma (81)
Machine learning (2)
Management (6)
Manufacturing (34)
MASH (21)
Medical device (3874)
Medtech (3874)
Mergers & acquisitions (3522)
Metabolic disorders (185)
Multiple sclerosis (34)
NASH (5)
Neurodegenerative disease (35)
Neuropsychiatric disorders (14)
Neuroscience (848)
NextGen: Class of 2025 (1802)
Non-profit (1772)
Northern California (1146)
Now hiring (5)
Obesity (72)
Opinion (26)
Ovarian cancer (44)
Pain (32)
Pancreatic cancer (37)
Parkinson's disease (76)
Partnered (3)
Patents (47)
Patient recruitment (49)
Peanut (21)
People (22133)
Pharmaceutical (9)
Phase I (10307)
Phase II (14503)
Phase III (10720)
Pipeline (408)
Podcasts (17)
Policy (20)
Postmarket research (1101)
Preclinical (3118)
Press Release (6)
Prostate cancer (42)
Psychedelics (32)
Radiopharmaceuticals (83)
Rare diseases (128)
Real estate (1052)
Recruiting (10)
Regulatory (6442)
Reports (8)
Research institute (1095)
Resumes & cover letters (14)
Rett syndrome (2)
RSV (3)
Schizophrenia (39)
Series A (51)
Series B (28)
Service/supplier (2)
Sickle cell disease (20)
Southern California (874)
Special edition (3)
Spinal muscular atrophy (59)
Sponsored (3)
Startups (1179)
Stomach cancer (3)
Supply chain (7)
The Weekly (9)
United States (8692)
Vaccines (169)
Venture capitalists (8)
Webinars (3)
Weight loss (26)
Women's health (7)
Worklife (1)
Date
Today (65)
Last 7 days (309)
Last 30 days (1115)
Last 365 days (12684)
2025 (2959)
2024 (13234)
2023 (15031)
2022 (17577)
2021 (19675)
2020 (17767)
2019 (14311)
2018 (10680)
2017 (10369)
2016 (9330)
2015 (11128)
2014 (8017)
2013 (5903)
2012 (6501)
2011 (6990)
2010 (5959)
Location
Africa (123)
Alabama (13)
Alaska (1)
Arizona (49)
Arkansas (5)
Asia (8903)
Australia (1185)
California (2379)
Canada (654)
China (124)
Colorado (82)
Connecticut (88)
Delaware (58)
Europe (20321)
Florida (267)
Georgia (83)
Idaho (10)
Illinois (178)
India (5)
Indiana (99)
Iowa (1)
Japan (48)
Kansas (39)
Kentucky (5)
Maine (4)
Maryland (849)
Massachusetts (1681)
Michigan (46)
Minnesota (106)
Missouri (20)
Montana (4)
Nebraska (7)
Nevada (12)
New Hampshire (9)
New Jersey (618)
New Mexico (6)
New York (592)
North Carolina (347)
North Dakota (1)
Northern California (1146)
Ohio (72)
Oklahoma (4)
Oregon (15)
Pennsylvania (548)
Puerto Rico (1)
Rhode Island (7)
South America (143)
South Carolina (5)
Southern California (874)
Tennessee (29)
Texas (337)
Utah (56)
Virginia (21)
Washington D.C. (11)
Washington State (186)
Wisconsin (18)
202,966 Results for "md biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Walden Biosciences Appoints Howard Mayer, M.D. to Board of Directors
January 28, 2025
·
3 min read
Press Releases
Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer
January 21, 2025
·
8 min read
Business
MBX Biosciences Appoints Salomon Azoulay, M.D., as Chief Medical Officer
MBX Biosciences, Inc. today announced the appointment of Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (CMO).
June 25, 2024
·
3 min read
Business
Precision BioSciences Expands Hepatitis Scientific Advisory Board with Addition of World-Class Clinical Investigators Mark Sulkowski, M.D. and Jordan Feld, M.D., MPH, as PBGENE-HBV Program Nears Clinical Readiness
Precision BioSciences Expands Hepatitis Scientific Advisory Board with Addition of World-Class Clinical Investigators Mark Sulkowski , M.D. and Jordan Feld, M.D., MPH, as PBGENE-HBV Program Nears Clinical Readiness.
June 20, 2024
·
11 min read
Press Releases
Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer
January 8, 2025
·
7 min read
Press Releases
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors
March 12, 2025
·
8 min read
Business
Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors
Tyra Biosciences, Inc., a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor biology, announced changes to its Board of Directors with the appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. as independent directors, and the resignation of Isan Chen, M.D.
May 7, 2024
·
6 min read
Press Releases
Atavistik Bio Announces Appointment of William Sellers, M.D. to its Scientific Advisory Board
April 1, 2025
·
3 min read
Business
MBX Biosciences Appoints Steven Ryder, M.D., to Board of Directors
MBX Biosciences, Inc. today announced the appointment of Steven Ryder, M.D., Chief Medical Officer of Rallybio, to its Board of Directors.
February 5, 2024
·
3 min read
Business
Tome Biosciences Appoints Industry Veteran Daniel Curran, MD, to its Board of Directors
Tome Biosciences, Inc., the programmable genomic integration company, announces the appointment of Daniel Curran, MD, to its Board of Directors.
January 30, 2024
·
2 min read
1 of 20,297
Next
